Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings outcomes in the present day.
Revenues have been $16.7 billion, down 6% on a reported foundation and seven% on an operational foundation year-over-year.
Web earnings decreased 21% to $3.5 billion, or $0.62 per share, in comparison with final 12 months. Adjusted EPS declined 18% to $0.87.
Income and earnings beat expectations.
For the total 12 months of 2025, Pfizer expects income of $61-64 billion. Adjusted EPS is now anticipated to be $3.00-3.15.
The inventory stayed purple throughout premarket hours on Tuesday.
Prior efficiency
